Our publication of a clinical trial investigating the effects of ProAlgaZyme on
Metabolic Syndrome and markers of cardiovascular health.

Click to read summary:
http://www.lipidworld.com/content/6/1/20

You may also download the full article as a PDF file with color graphs:
http://www.lipidworld.com/content/pdf/1476-511x-6-20.pdf

The article was published in Lipids in Health and Disease,
a free open-access journal in the BioMed Central network of journals.

ProAlgaZyme (4 fl oz daily) consumption resulted in significant reductions in weight and blood glucose levels, while significantly improving serum lipid
profiles and reducing markers of inflammation, thus improving
cardiovascular risk factors over a course of 10 weeks.